Toshiba Corp Chairman Osamu Nagayama and another board member failed to get shareholder approval for their reappointments, as nine of the other candidates were approved.
Nagayama was under pressure to resign after an independent investigation revealed that Toshiba officials colluded with the Japanese government to control foreign investors’ influence.
Major shareholders and investment fund Effissimo alleged that Toshiba didn't fairly carry out Effissimo's nomination of dissident directors.
They demanded Nagayama's ouster as the latter has the most responsibility in nominating candidates and on the board's behavior.
Besides Effissimo, which owns a 10 percent stake in Toshiba, other foreign investors include Harvard University’s endowment fund and 3D Investment Partners.
Nagayama had vowed to restore transparency, get to the bottom of what happened, and prevent a recurrence.
In an open letter to shareholders, Nagayama sought backing for his reappointment, pledging to be an agent of positive change rather than as a protector of the status quo.


India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Instagram Outage Disrupts Thousands of U.S. Users
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



